Broadening Diversity in Genomics: The BabySeq Experience
Presenter(s): Drs Robert Green and Ingrid Holm, BabySeq
Broadening Diversity in Genomics: The Babyseq Experience
Clinical development of therapeutic platforms for monogenic diseases and implications for NBS
Presenter: Dr Philip J. (P.J.) Brooks, NIH
Clinical development of therapeutic platforms for monogenic diseases and implications for NBS
Societal Implications of gNBS
Presenter: Dr Wendy Chung, GUARDIAN Study
Societal Implications of gNBS
Investor's perspective on NBSeq
Presenter: Dr Walt Kowtoniuk, Third Rock Ventures
Investor's perspective on NBSeq
Private/Public Debate
Moderator: Dr Stephen Kingsmore, BeginNGS
Panelists: Dr Walt Kowtoniuk (Third Rock Ventures), Hans Keil (Nurture Genomics), Amy Gaviglio (CDC), Dr Jeff Brosco (HRSA)
What might the future look like?
Keynote Presentation: Newborn Sequencing and Perspectives in Sickle Cell Disease Therapeutics
Presenter: Dr Ambroise Wonkam, MD PhD, Professor of Genetic Medicine, and Director, McKusick-Nathans Institute & Department of Genetic Medicine. Johns Hopkins School of Medicine
Newborn Sequencing and Perspectives in Sickle Cell Disease Therapeutics
Newborn Sequencing in the Social Context
Moderator: Dr Ana Iltis. Director, Center for Bioethics, Health and Society, Wake Forest Univ.
Panelists: Dr Ammira Akil (Qatar Newborn Genome Sequencing), Dr Sebastian Lunke (BabyScreen+), Dr Francois Boemer (BabyDetect), Dr Melissa Wasserstein (ScreenPlus)
Newborn Sequencing in the Social Context
A Look Back: NBS & Robert Guthrie
Presenter: Patricia Guthrie
A Look Back: Successes and Learnings
Fireside Chat: From Guthrie to Newborn Sequencing
Moderator: Dr David Bick, ICoNS Co-Chairman, Generation Study
Guests: Patricia Guthrie & Dr Edwin Naylor
Closing Announcements (ICoNS'25)
Nicolas Encina, Exec. Director ICoNS, Director of Strategy Precision Population Health, Ariadne Labs, Harvard School of Public Health
Announcing ICoNS’25